(Date:7/25/2008)...stCall/ -- Thoratec,Corporation (Nasdaq: THOR ) a...ry support therapies to save, support and restore ...t its operating results for the second,quarter and... 31., The company will hold a conference call to ...ties to all interested parties at 1:30 p.m.,Pacif...
(Date:7/25/2008)...or obese is not only a personal issue that affects...at impacts other people in society. A new study in...at the extra Medicare cost associated with overwei...cial burden on tax payers, costing up to hundreds ...edicare population. , The article,s findings sh...
(Date:7/25/2008)...y.com announces the,availability of Trade Alerts o...ll of the daily trading notes for free by visiting...ts include: DUSA Pharmaceuticals Inc. (Nasdaq: DU...BRK ), NovaMed Inc. (Nasdaq:,NOVA), Adolor Corp. (...and,Abaxis Inc. (Nasdaq: ABAX )., Join investor ...
(Date:7/25/2008)...ense and Federal Agencies in, the execution of Op...s a, four-day, multi-agency collaborative traini...cal agencies with large and complex incident respo...d-hoc, secure mobile communications infrastructu... Va., July 25 /PRNewswire/ -- Dataline LLC is plea...
Breaking Medicine News(10 mins):Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3...to that apple or lentils, for a new study has foun...lowly once they have been consumed helps dieters l...ood sugar levels. Foods that release sugars rapid... index - those that release it slowly have a low g...
...mours once again when she was pictured with baby b...re of John Travolta starrer Hairspray dressed in a... her bump, reports the Daily Mail. Holmes sparked...nd hubby Tom Cruise were expecting their second ch...
...t a government-run district hospital in Chhattisga...grawal told the state assembly Tuesday . Amid prot...mbers about the lack of basic medical facilities a...spital in Raigarh district had reported 424 deaths...
...mulation models suggests that the lifetime risk of... computed tomography (CT scan) coronary angiograph...nd younger patients. Coronary artery disease (CAD...and women in the United States, accounting for 1 i...
Other Medicine News:Health News:Apples and Lentils Could Help You to Shed Off Those Extra Pounds! 2Health News:CT Scan Radiations may Lead to Cancer 2(Date:7/24/2008)...RNewswire-USNewswire/ -- Headlines claiming "soy,p...tory. The small scale,preliminary study that Dr. ...tion, is based on recollected intake of soyfoods a...s study is confounded by many,issues, thus I feel ...caution," warned Dr. Tammy Hedlund, a researcher i...
(Date:7/23/2008)...roved Systemic Therapy to Treat the Disease -, WA...ire-FirstCall/ --,Bayer HealthCare Pharmaceuticals...ay announced that The New England Journal of Medic...ting that Nexavar(R) (sorafenib),tablets decreased...nts with,unresectable hepatocellular carcinoma (HC...
(Date:7/23/2008)...Areas of the Body Have Greater Concentrations of,S...wswire-USNewswire/ -- Fat removed,from the lower a...nd to be,an excellent source of stem cells, with h... the body, reports a Brazilian-based study in Augu...ficial medical journal of the,American Society of ...
(Date:7/22/2008)...lts from a multi-center 293-patient European, tri...xchange Symbol: CYT, MONTREAL, July 22 /PRNewswir...global leader in cryotherapy products to treat car...viously presented from three,European study center...),were published earlier today in the Journal of ...
Breaking Medicine Technology:Soyfoods Do Not Impact Sperm Count 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Spectral appoints Anthony Bihl to Board of Directors 3774 1Spectral appoints Anthony Bihl to Board of Directors 3774 2Smoking Boosts Bleeding Stroke Risk in Those With High Blood Pressure 13727 1Smoking Boosts Bleeding Stroke Risk in Those With High Blood Pressure 13727 2Rheumatoid Arthritis Drugs May Lower Heart Attack Stroke Risk 13725 1Rheumatoid Arthritis Drugs May Lower Heart Attack Stroke Risk 13725 2Function of molecular switch pinpointed in severe congenital neutropenia 13723 1Function of molecular switch pinpointed in severe congenital neutropenia 13723 2Function of molecular switch pinpointed in severe congenital neutropenia 13723 3...es Positive Data in Nonclinical (IND) In- Vitro,St...ay 3, 2007 (PRIME NEWSWIRE) -- Samaritan,Pharmaceu...drugs,is pleased to announce positive results wer...ical testing of Caprospinol (SP-233),with well re...esearch results are imperfect predictors,of clinic...
...., May 02, 2007 /PRNewswire/ -- Ceregene, Inc.,tod...trial of,CERE-110, a gene therapy product designed...tment of Alzheimer,s disease. After one,year of fo...ived,CERE-110 in the trial indicate that a single ...and an interim analysis suggested that,the therapy...
Other Medicine Technology:Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 2Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 3Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the,Treatment of Alzheimer's Disease 2Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the,Treatment of Alzheimer's Disease 3Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the,Treatment of Alzheimer's Disease 4Curved shafts and tips with 6 mm tying platform. Wide serrated handle with dull finish. Overall length 4.3 inches.
Curved shafts and tips with 5.5 mm tying platform. 0.3 mm gap at platform heel. True round knurled handle in closed position with polished finish. Overall length 4.3 inches.
5 mm tying platform. Round knurled handle with dull finish. Curved shafts. Overall length 3.9 inches.
Slightly curved 10 mm jaws and serrated cross action handle with polished finish. Overall length 4.6 inches.
Medicine Products: